Viewing Study NCT06075758


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2025-12-25 @ 10:05 PM
Study NCT ID: NCT06075758
Status: RECRUITING
Last Update Posted: 2025-01-14
First Post: 2023-10-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module